These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11870441)

  • 1. Spectrum of abdominal sonographic findings in 103 pediatric patients with Gaucher disease.
    Patlas M; Hadas-Halpern I; Abrahamov A; Elstein D; Zimran A
    Eur Radiol; 2002 Feb; 12(2):397-400. PubMed ID: 11870441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenic nodules in paediatric Gaucher disease treated by enzyme replacement therapy.
    Chippington S; McHugh K; Vellodi A
    Pediatr Radiol; 2008 Jun; 38(6):657-60. PubMed ID: 18379770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaucher disease: spectrum of sonographic findings in the liver.
    Hadas-Halpern I; Deeb M; Abrahamov A; Zimran A; Elstein D
    J Ultrasound Med; 2010 May; 29(5):727-33. PubMed ID: 20427784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease.
    Andrade-Campos M; Alfonso P; Irun P; Armstrong J; Calvo C; Dalmau J; Domingo MR; Barbera JL; Cano H; Fernandez-Galán MA; Franco R; Gracia I; Gracia-Antequera M; Ibañez A; Lendinez F; Madruga M; Martin-Hernández E; O'Callaghan MDM; Del Soto AP; Del Prado YR; Sancho-Val I; Sanjurjo P; Pocovi M; Giraldo P
    Orphanet J Rare Dis; 2017 May; 12(1):84. PubMed ID: 28468677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the liver and spleen in children with Gaucher disease type I with diffusion-weighted MR imaging.
    Razek AAKA; Abdalla A; Barakat T; El-Taher H; Ali K
    Blood Cells Mol Dis; 2018 Feb; 68():139-142. PubMed ID: 28012701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Liver and Spleen in Children With Gaucher Disease Type 1 With Chemical Shift Imaging.
    Abdel Razek AAK; Barakat T; Ali K
    J Comput Assist Tomogr; 2019; 43(2):183-186. PubMed ID: 30407244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
    Duan YL; Zhang YH; Zang Y; Shi HP; Zhang WM; Hu YM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):653-6. PubMed ID: 17217655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme replacement therapy for Gaucher disease in Australia.
    Goldblatt J; Szer J; Fletcher JM; McGill J; Rowell JA; Wilson M
    Intern Med J; 2005 Mar; 35(3):156-61. PubMed ID: 15737135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
    Tóth J; Szücs FZ; Benkö K; Maródi L
    Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease.
    Drelichman G; Ponce E; Basack N; Freigeiro D; Aversa L; Graciela E; Kohan R
    J Pediatr; 2007 Aug; 151(2):197-201. PubMed ID: 17643778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imiglucerase low-dose therapy for paediatric Gaucher disease--a long-term cohort study.
    Heitner R; Arndt S; Levin JB
    S Afr Med J; 2004 Aug; 94(8):647-51. PubMed ID: 15352589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow response in treated patients with Gaucher disease: evaluation by T1-weighted magnetic resonance images and correlation with reduction in liver and spleen volume.
    Terk MR; Dardashti S; Liebman HA
    Skeletal Radiol; 2000 Oct; 29(10):563-71. PubMed ID: 11127678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cessation of enzyme replacement therapy in Gaucher disease.
    Grinzaid KA; Geller E; Hanna SL; Elsas LJ
    Genet Med; 2002; 4(6):427-33. PubMed ID: 12509713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat abdominal ultrasound evaluation of 100 patients with type I Gaucher disease treated with enzyme replacement therapy for up to 7 years.
    Patlas M; Hadas-Halpern I; Abrahamov A; Zimran A; Elstein D
    Hematol J; 2002; 3(1):17-20. PubMed ID: 11960391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominal ultrasound findings mimicking hematological malignancies in a study of 218 Gaucher patients.
    Neudorfer O; Hadas-Halpern I; Elstein D; Abrahamov A; Zimran A
    Am J Hematol; 1997 May; 55(1):28-34. PubMed ID: 9136914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of enzyme replacement therapy in Turkish patients with Gaucher disease: does late intervention affect the response?
    Arikan-Ayyildiz Z; Yüce A; Emre S; Baysoy G; Saltik-Temizel IN; Gürakan F
    Turk J Pediatr; 2011; 53(5):499-507. PubMed ID: 22272449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of bone marrow response with hematological, biochemical, and visceral responses to enzyme replacement therapy of nonneuronopathic (type 1) Gaucher disease in 30 adult patients.
    Poll LW; Koch JA; Willers R; Aerts H; Scherer A; Häussinger D; Mödder U; vom Dahl S
    Blood Cells Mol Dis; 2002; 28(2):209-20. PubMed ID: 12064917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term velaglucerase alfa treatment in children with Gaucher disease type 1 naïve to enzyme replacement therapy or previously treated with imiglucerase.
    Smith L; Rhead W; Charrow J; Shankar SP; Bavdekar A; Longo N; Mardach R; Harmatz P; Hangartner T; Lee HM; Crombez E; Pastores GM
    Mol Genet Metab; 2016 Feb; 117(2):164-71. PubMed ID: 26043810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease.
    Wenstrup RJ; Kacena KA; Kaplan P; Pastores GM; Prakash-Cheng A; Zimran A; Hangartner TN
    J Bone Miner Res; 2007 Jan; 22(1):119-26. PubMed ID: 17032149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report of the Spanish Gaucher's disease registry: clinical and genetic characteristics.
    Giraldo P; Pocoví M; Pérez-Calvo J; Rubio-Félix D; Giralt M
    Haematologica; 2000 Aug; 85(8):792-9. PubMed ID: 10942924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.